01 Apr 2020
Client briefing on the antitrust implications of COVID-19 in Hong Kong and across APAC, including issues such as competitor collaborations, excessive pricing and restriction of supply of critical goods, and impact on merger control.
This material is provided for general information only. It does not constitute legal or other professional advice.
Are you sure want to delete comment ?
Scan this QR Code to share this content